Analysis of Serum IgG1 to Predict Progression and Therapeutic Effect in Patients with Multiple Myeloma

Table 7

Concentration of serum monoclonal proteins in patients with multiple myeloma before, during, and after treatment.

	Before treatment	During treatment	After treatment
IgA (N = 84)	28.80 ± 23.72	10.80 ± 11.98	9.90 ± 13.92
IgG (N = 185)	50.69 ± 33.24	17.43 ± 13.16	13.25 ± 10.19^#
IgG1 (N = 91)	37.45 ± 21.30	11.71 ± 6.92	7.95 ± 3.54
IgG2 (N = 21)	17.11 ± 10.54	9.59 ± 5.45	7.6 ± 9.01
IgG3 (N = 28)	5.82 ± 7.38	0.84 ± 0.49	0.66 ± 0.39
IgG4 (N = 16)	35.51 ± 30.32	12.82 ± 18.92	13.87 ± 7.26

Compared with the before treatment group, ; compared with the during treatment group, .